Facial recognition technology highly beneficial in genetic medicine
DeepGestalt achieved 91% accuracy in identifying the correct syndrome on 502 images representing over 200 different genetic syndromes, and outperformed expert clinicians in three experiments.
An illustration of Israeli-founded company FDNA's DeepGestalt-powered Face2Gene platform(photo credit: Courtesy)ByEYTAN HALON